Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Gordon C S Smith a Department of Obstetrics
and Gynaecology, Cambridge University, Box 223, The Rosie Hospital,
Cambridge CB2 2QQ, b Department of Public Health,
Greater Glasgow Health Board, Dalian House, Glasgow G3 8YU, c Information
and Statistics Division, Common Services Agency, Edinburgh EH5
3SE Correspondence to: G C
S Smith gcss2{at}cam.ac.uk
We recently showed that complications in late pregnancy are
associated with an increased risk of maternal ischaemic heart disease
(IHD) in later life.1 We hypothesised that this may reflect common determinants, such as thrombophilic genetic defects and
anticardiolipin antibodies. Spontaneous losses of pregnancy are also
associated with inherited and acquired thrombophilias in the
mother.2 We examined whether spontaneous losses of early pregnancy are associated with maternal risk of IHD.
We used routine national maternity data (SMR2) to identify all
129 290 eligible women who delivered their first liveborn infant in
Scotland during 1981-5. The exclusion and inclusion criteria, definitions, and demographic characteristics were as previously described.1 We used national death (GRO) and discharge
(SMR1) data to determine the risk of death or hospital admission due to
IHD during 1981-99. The cumulative probabilities of survival free from
IHD events were assessed with Cox's proportional hazards models with
age as the time scale (Stata version 7.0, StataCorp, College Station,
TX,USA).
A history of any spontaneous loss of early pregnancy before the first
live birth was associated with an increased risk of IHD (table). The
association was independent of maternal age at the time of first birth,
height, socioeconomic deprivation, essential hypertension, and
complications during the first pregnancy. The magnitude of the risk
increased with the number of previous losses. By contrast, there was no
association between therapeutic abortion and subsequent risk of IHD
(adjusted hazard ratio 0.93, 95% confidence interval 0.59 to 1.46).
Only 0.1% (162) of women had had a hernia repair, and there was no
significant association with spontaneous early pregnancy loss (0.93, 0.55 to 1.59), suggesting that there was no bias due to selective
migration. We did not have data on the smoking status of women in the
1981-5 cohort. However, we had data on 181 636 women who had a first
livebirth from 1992 to 1998, inclusive. The proportion of women who
were current smokers at the first attendance for prenatal care was only
marginally higher among women with a history of spontaneous loss of
early pregnancy (28.4%) than among those with no such history
(26.8%).
To our knowledge, this is the first study to show a specific
association between spontaneous abortion and maternal risk of IHD. Our
findings may explain the results of previous studies that have found an
association between the total number of pregnancies and maternal risk
of IHD as women who suffer recurrent losses of early pregnancy must
have more pregnancies to achieve their target family
size.3 However, it is unlikely that the association between spontaneous abortion and maternal IHD is simply an effect of
parity as there was no association with therapeutic abortion.
The strengths of our study are that prospective data collection
precluded bias and, in contrast with a case-control study, we were able
to include women who subsequently died. However, further studies are
required to corroborate our findings and to confirm that the
association is independent of smoking and other confounding factors,
such as maternal disease (for example, diabetes and polycystic ovarian syndrome).
Several studies have shown associations between acquired and inherited
thrombophilias and both spontaneous loss of early pregnancy 2 and IHD.
4 5
Implantation of the embryo and
development of the placenta involve complex adaptations of the
mother's cardiovascular and microvascular systems. We hypothesise that
occult cardiovascular, microvascular, or haemostatic dysfunction result
in pregnancy complications during reproductive years and in overt
cardiovascular disease in later life. A woman's reproductive history
may, therefore, inform future cardiovascular risk.
![]()
Participants, methods, and results
Top
Participants, methods, and...
Comment
References
![]()
Comment
Top
Participants, methods, and...
Comment
References
| |
Acknowledgments |
|---|
Contributors: GCSS had the original concept, reviewed previous publications, undertook the statistical analyses, and is guarantor. GCSS and JPP wrote the initial draft. DW performed the record linkage. GCSS, JPP, and DW agreed the study design, interpreted the results, revised the original draft, and approved the final version.
| |
Footnotes |
|---|
Competing interests: None declared.
Funding: Chief Scientist Office, Scottish Executive Health Department (CZG/4/2/22).
| |
References |
|---|
|
|
|---|
| 1. | Smith GCS, Pell JP, Walsh D. Pregnancy complications and maternal risk of ischaemic heart disease: a retrospective cohort study of 129 290 births. Lancet 2001; 357: 2002-2006[CrossRef][Web of Science][Medline]. |
| 2. |
Souza SS, Ferriani RA, Pontes AG, Zago MA, Franco RF.
Factor V Leiden and factor II G20210A mutations in patients with recurrent abortion.
Hum Reprod
1999;
14:
2448-2450 |
| 3. |
Ness RB, Harris T, Cobb J, Flegal KM, Kelsey JL, Balanger A, et al.
Number of pregnancies and the subsequent risk of cardiovascular disease.
N Engl J Med
1993;
328:
1528-1533 |
| 4. |
Rosendaal FR, Siscovick DS, Schwartz SM, Beverly RK, Psaty BM, Longstreth Jr WT, et al.
Factor V Leiden (resistance to activated protein C) increases the risk of myocardial infarction in young women.
Blood
1997;
89:
2817-2821 |
| 5. | Vaarala O. Antiphospholipid antibodies and myocardial infarction. Lupus 1998; 7(suppl 2): S132-S134. |
(Accepted 12 December 2002)
Read all Rapid Responses